The global antiviral immunoglobulins market, valued at approximately USD 5.0 billion in 2023, is set to experience robust growth, with projections estimating its value to reach USD 10.9 billion by 2033. This growth represents an impressive compound annual growth rate (CAGR) of 7.4% over the forecast period from 2023 to 2033. Key Growth Drivers: Rising …